B. Guazzini

Hypertriglyceridemia and Hyperinsulinemia Are Potent Inducers of Endothelin-1 Release in Humans

L. Monti, A. Pontiroli, P. Piatti, 1996, Diabetes.

Effects of low-dose heparin infusion on arterial endothelin-1 release in humans.

L. Monti, A. Pontiroli, P. Piatti, 1996, Circulation.

Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (probe) trial.

E. Chebat, M. Bevilacqua, M. Barrella, 2004, Current therapeutic research, clinical and experimental.

Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity‐onset diabetes of the young (MODY)

G. Pozza, S. Bertolini, F. Meschi, 1998, Human mutation.

Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients.

G. Derosa, P. Maffioli, A. Bossi, 2011, European journal of pharmacology.

Circulating nitric oxide is modulated by recombinant human TSH administration during monitoring of thyroid cancer remnant

E. Molinari, F. Minuto, M. Giusti, 2003, Journal of endocrinological investigation.